Romatoid artrit [rheumatoid arthritis (RA)], en sık görülen otoimmün eklem hastalıklarından birisidir. Toplumun yaklaşık %0,5-1'ini etkileyen RA için mevcut hedefe yönelik tedavi protokolleri hastalık aktivitesini ölçer; konvansiyonel, steroid olmayan antiinflamatuar ilaçları [nonsteroidal anti-inflammatory drugs (NSAIDs)] ve metotreksat gibi biyolojik olmayan hastalık modifiye edici antiromatizmal ilaçları [disease-modifying antirheumatic drugs (DMARDs)] kullanır. Bununla birlikte tedavilerin bazılarına etkili şekilde yanıt vermeyen hastalar vardır ve verilen ilaçlar hastaları tatmin etmemektedir. Bu nedenle acilen yeni çözümlere ihtiyaç duyulduğu açıktır. Son zamanlarda tamamlayıcı ve alternatif tıp [complementary and alternative medicine(CAM)], RA tedavisinde son derece popülerdir. RA hastaları hayatlarında en az bir kez tamamlayıcı tedavilere başvurmuştur. CAM, genellikle modern tedavilerin yerine geçmek yerine onlara ek ve destekleyici olarak kullanılır. Mevcut biyolojik ilaçların sınırlamaları ve yan etkileri yüzünden, RA'lı birçok kişinin yüzünü CAM'a çevirmesi şaşırtıcı değildir. Aslında, bitkisel ilaçlar, diyet müdahalesi, manuel terapi, kalori kısıtlaması ve epigenomik yaklaşımlar kas-iskelet ağrısını azaltmada ümit vadetmektedir. Bu çalışmamız, RA tedavisinde CAM hakkında bilinenlere kısa bir genel bakış sağlar ve ayrıca yeşil çay, Tripterygium wilfordii, Curcuma longa, Veratrum grandiflorum ve Camellia sinensis gibi bitkilerin farmakolojik etkileri hakkında son bilgileri özetlemektedir. Bu derleme, ayrıca mikrobiyom, nütrigenomiks ve RA arasında bildirilen korelasyon ve altta yatan moleküler mekanizmaları da özetlemektedir. CAM tedavilerinin etkili olabileceği mekanizmaların derinlemesine anlaşılması ve netleştirilmesi RA semptomlarının azaltılmasında yeni moleküler ve besinsel hedeflerin keşfine yol açabilir ve RA hastaları için yeni tedavi olanakları sağlayabilir. Bunun sayesinde CAM ve konvansiyonel ilaç uygulamaların RA tedavisinde entegrasyonuna yardımcı olunabilir. Sonuç olarak burada, bazı rasyonel CAM modalitelerinin, RA tedavisindeki potansiyel rolünü incelemeyi amaçladık.
Anahtar Kelimeler: Geleneksel ve tamamlayıcı tıp; romatoid artrit
Rheumatoid arthritis (RA) is one of the most prevalent autoimmune inflammatory joint diseases. RA affecting approximately 0.5-1.0% of the population. Current treatment-to-target strategy for RA measure disease activity scores and use conventional, nonsteroidal anti-inflammatory drugs (NSAIDs), and non-biological disease-modifying antirheumatic drugs (DMARDs) as methotrexate. Hovewer, there is a significant proportion of patients who do not respond efficiently to some of these therapies which has been far from patient satisfaction. Therefore, it is apparent that novel remedies are urgently needed. Recently, complementary and alternative medicine (CAM) is extremely popular worldwide for the alleviation of RA. Many RA patients frequently seek CAM at once in her/his life. CAM is usually used in addition to, and not as a substitute for conventional therapies. Given the poor effect of current drugs and the side effects, it is not at all surprising that many individuals with RA turn their face to CAM. Herbal medicines, dietary intervention, manuel therapy, calori restriction and epigenomic approach are promising in reducing musculoskeletal pain. This study provides a brief overview of what is known about CAM as a treatment for RA and will also summarize recent data for pharmacological effects of herbs including green tea, Tripterygium wilfordii, Curcuma longa, Veratrum grandiflorum and Camellia sinensis. Here we also summarise reported correlation and underlying molecular mechanisms among microbiome, nutriogenomics and RA. Deep understanding and clarification of the subtle mechanisms by which CAM therapies may be efficacious can be lead to discovering new molecular and nutritional targets in the relieving symptoms and provide new treatment opportunities for RA patients. This may assist the integration of CAM and conventional practices in the treatment of RA. Collectively, we aimed here to examine the potential role of some rationale CAM modalities in RA therapy.
Keywords: Traditional and complementary medicine; rheumatoid arthritis
- Deng G, Cassileth B. Complementary or alternative medicine in cancer care-myths and realities. Nat Rev Clin Oncol. 2013;10(11):656-64. [Crossref] [PubMed]
- Ernst E. How much of CAM is based on research evidence? Evid Based Complement Alternat Med. 2011;2011:676490. [Crossref] [PubMed] [PMC]
- Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis. 2017;20(4):417-19. [Crossref] [PubMed]
- Chen W, Li EC, Zheng WR. Policies on Chinese medicine in China may have enlightenments to complementary and alternative medicine in the world. Chin J Integr Med. 2018;24(10):789-93. [Crossref] [PubMed]
- Efferth T, Zacchino S, Georgiev MI, Liu L, Wagner H, Panossian A. Nobel Prize for artemisinin brings phytotherapy into the spotlight. Phytomedicine. 2015;22(13):A1-3. [Crossref] [PubMed]
- Astin JA. Why patients use alternative medicine: results of a national study. JAMA. 1998;279(19):1548-53. [Crossref] [PubMed]
- Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001. [Crossref] [PubMed]
- Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. [Crossref] [PubMed]
- Viatte S, Barton A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Semin Immunopathol. 2017;39(4):395-408. [Crossref] [PubMed] [PMC]
- Lambert NC. Nonendocrine mechanisms of sex bias in rheumatic diseases. Nat Rev Rheumatol. 2019;15(11):673-86. [Crossref] [PubMed]
- Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376-81. [PubMed]
- Tuncer T, Gilgil E, Kaçar C, Kurtaiş Y, Kutlay Ş, Bütün B, et al. Prevalence of rheumatoid arthritis and spondyloarthritis in Turkey: a nationwide study. Arch Rheumatol. 2017;33(2):128-36. [Crossref] [PubMed] [PMC]
- Balkrishna A, Sakat SS, Joshi K, Paudel S, Joshi D, Joshi K, et al. Herbo-mineral formulation 'Ashwashila' attenuates rheumatoid arthritis symptoms in collagen-antibody-induced arthritis (CAIA) mice model. Sci Rep. 2019;9(1):8025. [Crossref] [PubMed] [PMC]
- Zhang Y, Dennis JA, Bishop FL, Cramer H, Leach M, Lauche R, et al. Complementary and alternative medicine use by U.S. adults with self-reported doctor-diagnosed arthritis: results from the 2012 National Health Interview Survey. PM R. 2019;11(10):1059-69. [Crossref] [PubMed]
- van Vollenhoven R. Treat-to-target in rheumatoid arthritis - are we there yet? Nat Rev Rheumatol. 2019;15(3):180-6. [Crossref] [PubMed]
- Falzer PR. Treat-to-target and shared decision making in rheumatoid arthritis treatment: is it feasible? Int J Rheum Dis. 2019;22(9):1706-13. [Crossref] [PubMed]
- Kalyoncu U, Ertenli Aİ, Kücükşahin O, Dalkılıç HE, Erden A, Bes C, et al. TReasure Çalışma Grubu. [Switching between biological DMARDs and associated reasons in rheumatoid arthritis and spondyloarthritis treatments: TReasure study-real life data]. J Turk Soc Rheumatol. 2019;11(1):1-9. [Crossref]
- Alarcón GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 1995;21(3):589-604. [PubMed]
- Ernst E, Posadzki P. Complementary and alternative medicine for rheumatoid arthritis and osteoarthritis: an overview of systematic reviews. Curr Pain Headache Rep. 2011;15(6):431-7. [Crossref] [PubMed]
- Tamhane A, McGwin Jr G, Redden DT, Hughes LB, Brown EE, Westfall AO, et al. Complementary and alternative medicine use in African Americans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014;66(2):180-9. [Crossref] [PubMed] [PMC]
- Chen L, Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ. 2017;357:j1284. [Crossref] [PubMed]
- Nahin RL, Dahlhamer JM, Taylor BL, Barnes PM, Stussman BJ, Simile CM, et al. Health behaviors and risk factors in those who use complementary and alternative medicine. BMC Public Health. 2007;7:217. [Crossref] [PubMed] [PMC]
- Tarner IH, Müller-Ladner U. Drug delivery systems for the treatment of rheumatoid arthritis. Expert Opin Drug Deliv. 2008;5(9):1027-37. [Crossref] [PubMed]
- Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med. 1999;131(6):409-16. [Crossref] [PubMed]
- Orr DE, Bravo Gutiérrez GB, Fette D. From parallel to partnership. Leadersh Health Serv (Bradf Engl). 2019;32(4):493-508. [Crossref] [PubMed]
- Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991;338(8772):899-902. [Crossref] [PubMed]
- Müller H, Wilhelmi de Toledo F, Resch KL. A systematic review of clinical studies on fasting and vegetarian diets in the treatment of rheumatoid arthritis. Scand J Rheumatol. 2000;30:1-10.
- Fontana L, Partridge L, Longo VD. Extending healthy life span--from yeast to humans. Science. 2010;328(5976):321-6. [Crossref] [PubMed] [PMC]
- Michalsen A, Li C. Fasting therapy for treating and preventing disease - current state of evidence. Forsch Komplementmed. 2013;20(6):444-53. [Crossref] [PubMed]
- Darlington LG, Ramsey NW, Mansfield JR. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet. 1986;1(8475):236-8. [Crossref] [PubMed]
- Sköldstam L, Larsson L, Lindström FD. Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol. 1979;8(4):249-55. [Crossref] [PubMed]
- Udén AM, Trang L, Venizelos N, Palmblad J. Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis. 1983;42(1):45-51. [Crossref] [PubMed] [PMC]
- Hafström I, Ringertz B, Gyllenhammar H, Palmblad J, Harms-Ringdahl M. Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum. 1988;31(5):585-92. [Crossref] [PubMed]
- Lindstrom TM, Robinson WH. Rheumatoid arthritis: a role for immunosenescence? J Am Geriatr Soc. 2010;58(8):1565-75. [Crossref] [PubMed] [PMC]
- Häger J, Bang H, Hagen M, Frech M, Träger P, Sokolova MV, et al. The role of dietary fiber in rheumatoid arthritis patients: a feasibility study. Nutrients. 2019;11(10):2392. [Crossref] [PubMed] [PMC]
- Ohsumi Y. Historical landmarks of autophagy research. Cell Res. 2014;24(1):9-23. [Crossref] [PubMed] [PMC]
- Jaspers RT, Zillikens MC, Friesema ECH, delli Paoli G, Bloch W, Uitterlinden AG, et al. Exercise, fasting, and mimetics: toward beneficial combinations? FASEB J. 2017;31(1):14-28. [Crossref] [PubMed]
- Levine B, Kroemer G. biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1-2):11-42. [Crossref] [PubMed] [PMC]
- Leidal AM, Levine B, Debnath J. Autophagy and the cell biology of age-related disease. Nat Cell Biol. 2018;20(12):1338-48. [Crossref] [PubMed]
- Miyauchi T, Uchida Y, Kadono K, Hirao H, Kawasoe J, Watanabe T, et al. Up-regulation of FOXO1 and reduced inflammation by β-hydroxybutyric acid are essential diet restriction benefits against liver injury. PNAS. 2019;116(27):13533-42. [Crossref] [PubMed] [PMC]
- Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol. 2005;202(3):289-301. [Crossref] [PubMed]
- Isner JM, Sours HE, Paris AL, Ferrans VJ, Roberts WC: Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet. Observations in 17 patients and the role of the prolonged QT interval. Circulation. 1979;60(6):1401-12. [Crossref] [PubMed]
- Spencer IO. Death during therapeutic starvation for obesity. Lancet. 1968;1(7555):1288-90. [Crossref] [PubMed]
- Frattali VP. Deaths associated with the liquid protein diet. Bull Natl Clgh Poison Control Cent. 1979;23(4):4-11. [PubMed]
- Hearing SD. Refeeding syndrome. BMJ. 2004;328(7445):908-9. [Crossref] [PubMed] [PMC]
- Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14(6):810-23. [Crossref] [PubMed] [PMC]
- Askari A. The sodium pump and digitalis drugs: dogmas and fallacies. Pharmacol Res Perspect. 2019;7(4):e00505. [Crossref] [PubMed] [PMC]
- DeSalvo JC, Skiba MB, Howe CL, Haiber KE, Funk JL. Natural product dietary supplement use by individuals with rheumatoid arthritis: a scoping review. Arthritis Care Res (Hoboken). 2019;71(6):787-97. [Crossref] [PubMed] [PMC]
- Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002-2012. Natl Health Stat Report. 2015;(79):1-16.
- Rose G. Why do patients with rheumatoid arthritis use complementary therapies? Musculoskeletal Care. 2006;4(2):101-15. [Crossref] [PubMed]
- Dudics S, Langan D, Meka RR, Venkatesha SH, Berman BM, Che CT, et al. Natural products for the treatment of autoimmune arthritis: their mechanisms of action, targeted delivery and interplay with the host microbiome. Int J Mol Sci. 2018;19(9):2508. [Crossref] [PubMed] [PMC]
- Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma Longa). Cancer Lett. 1985;29(2):197-202. [Crossref] [PubMed]
- Haroyan A, Mukuchyan V, Mkrtchyan N, Minasyan N, Gasparyan S, Sargsyan A, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018;9;18(1):7. [Crossref] [PubMed] [PMC]
- Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620-37. [Crossref] [PubMed] [PMC]
- Zheng Z, Sun Y, Liu Z, Zhang M, Li C, Cai H. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Des Devel Ther. 2015;9:4931-42. [Crossref] [PubMed] [PMC]
- Kapoor B, Gupta R, Gupta M. Natural products in treatment of rheumatoid arthritis. Int J Green Pharm. 2017;11:S356-63.
- Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717-29. [Crossref] [PubMed] [PMC]
- Conigliaro P, Triggianese P, De Martino E, Fonti GL, Chimenti MS, Sunzini F, et al. Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev. 2019;18(7):706-13. [Crossref] [PubMed]
- Javadi M, Khadem Haghighian H, Goodarzy S, Abbasi M, Nassiri-Asl M. Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: a randomized, double-blind, controlled trial. Int J Rheum Dis. 2019;22(10):1857-62. [Crossref] [PubMed]
- Priyadarsini KI. Chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des. 2013;19(11):2093-100. [Crossref] [PubMed]
- Concetta Scuto M, Mancuso C, Tomasello B, Laura Ontario M, Cavallaro A, Frasca F, et al. Curcumin, hormesis and the nervous system. Nutrients. 2019;11(10):2417. [Crossref] [PubMed] [PMC]
- Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. 2010;13(11):1763-811. [Crossref] [PubMed] [PMC]
- Du L, Wang L, Wang B, Wang J, Hao M, Chen YB, et al. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling. Acta Pharmacol Sin. 2019;41(3):358-72. [Crossref] [PubMed]
- Rao YL, Ganaraja B, Joy T, Pai MM, Ullal SD, Murlimanju BV. Neuroprotective effects of resveratrol in Alzheimer's disease. Front Biosci (Elite Ed). 2020;12:139-49. [Crossref] [PubMed]
- Takaoka M. Takaoka M. Resveratrol (3,4′,5-trihydroxy-trans-stilbene; Fig. 1) was first isolated in 1939 by Takaoka from Veratrum grandiflorum O. Loes (root of the white hellebore). J Chem Soc Jpn. 1939;60:1090-100. [Crossref]
- Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506. [Crossref] [PubMed]
- Gan Z, Wei W, Wu J, Zhao Y, Zhang L, Wang T, et al. Resveratrol and curcumin improve intestinal mucosal integrity and decrease m6A RNA methylation in the intestine of weaning piglets. ACS Omega. 2019;4(17):17438-46. [Crossref] [PubMed] [PMC]
- Zhang Y, Wang G, Wang T, Cao W, Zhang L, Chen X. Nrf2-Keap1 pathway-mediated effects of resveratrol on oxidative stress and apoptosis in hydrogen peroxide-treated rheumatoid arthritis fibroblast-like synoviocytes. Ann N Y Acad Sci. 2019;1457(1):166-78. [Crossref] [PubMed]
- Yang G, Chang CC, Yang Y, Yuan L, Xu L, Ho CT, et al. Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis. J Agric Food Chem. 2018;66(49):12953-60. [Crossref] [PubMed]
- Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369-80. [Crossref] [PubMed] [PMC]
- Lomholt S, Mellemkjaer A, Iversen MB, Pedersen SB, Kragstrup TW. Resveratrol displays anti-inflammatory properties in an ex vivo model of immune mediated inflammatory arthritis. BMC Rheumatol. 2018;2:27. [Crossref] [PubMed] [PMC]
- Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin Rheumatol. 2018;37(8):2035-42. [Crossref] [PubMed]
- Pezzuto JM. Resveratrol: twenty years of growth, development and controversy. Biomol Ther (Seoul). 2019;27(1):1-14. [Crossref] [PubMed] [PMC]
- Bao J, Dai SM. A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety. Rheumatol Int. 2011;31(9):1123-9. [Crossref] [PubMed]
- Chen SR, Dai Y, Zhao J, Lin L, Wang Y, Wang Y. A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F. Front Pharmacol. 2018;9:104. [Crossref] [PubMed] [PMC]
- Venkatesha SH, Yu H, Rajaiah R, Tong L, Moudgil KD. Celastrus-derived celastrol suppresses autoimmune arthritis by moulating antigen-induced cellular and humoral effector responses. J Biol Chem. 2011;286(17):15138-46. [Crossref] [PubMed] [PMC]
- Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U. Treatment of obesity with celastrol. Cell. 2015;161(5):999-1011. [Crossref] [PubMed] [PMC]
- Jiang M, Zha Q, Zhang C, Lu C, Yan X, Zhu W, et al. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial. Sci Rep. 2015;5:9700. [Crossref] [PubMed] [PMC]
- Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A. 1999;96(8):4524-9. [Crossref] [PubMed] [PMC]
- Ahmed S, Marotte H, Kwan K, Ruth JH, Campbell PL, Rabquer BJ, et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc Natl Acad Sci U S A. 2008;105(38):14692-7. [Crossref] [PubMed] [PMC]
- Pervin M, Unno K, Takagaki A, Isemura M, Nakamura Y. Function of green tea catechins in the brain: epigallocatechin gallate and its metabolites. Int J Mol Sci. 2019;20(15):3630. [Crossref] [PubMed] [PMC]
- Oliviero F, Scanu A, Zamudio-Cuevas Y, Punzi L, Spinella P. Anti-inflammatory effects of polyphenols in arthritis. J Sci Food Agric. 2018;98(5):1653-9. [Crossref] [PubMed]
- Bhutia Pemba H, Sharangi Baran AB, Lepcha R, Tamang D. Bioactive compounds and antioxidant properties of tea: status, global research and potentialities. J Tea Sci Res. 2015;5(11):1-13. [Crossref]
- Ramadan G, El-Beih NM, Talaat RM, Abd El-Ghffar EA. Anti-inflammatory activity of green versus black tea aqueous extract in a rat model of human rheumatoid arthritis. Int J Rheum Dis. 2017;20(2):203-13. [Crossref] [PubMed]
- Min SY, Yan M, Kim SB, Ravikumar S, Kwon SR, Vanarsa K, et al. Green tea epigallocatechin-3-gallate suppresses autoimmune arthritis through indoleamine-2,3-dioxygenase expressing dendritic cells and the nuclear factor, erythroid 2-like 2 antioxidant pathway. J Inflamm (Lond). 2015;12:53. [Crossref] [PubMed] [PMC]
- Wang H, Li S, Zhang G, Wu H, Chang X. Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation. Arthritis Res Ther. 2019;21(1):220. [Crossref] [PubMed] [PMC]
- Rambod M, Nazarinia M, Raieskarimian F. The impact of dietary habits on the pathogenesis of rheumatoid arthritis: a case-control study. Clin Rheumatol. 2018;37(10):2643-8. [Crossref] [PubMed]
- Lamichhane D, Collins C, Constantinescu F, Walitt B, Pettinger M, Parks C, et al. Coffee and tea consumption in relation to risk of rheumatoid arthritis in the women's health ınitiative observational cohort. J Clin Rheumatol. 2019;25(3):127-132. [Crossref] [PubMed] [PMC]
- Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr. 2004;80(6):1558-64. [Crossref] [PubMed]
- Maeda Y, Takeda K. Role of gut microbiota in rheumatoid arthritis. J Clin Med. 2017;6(6):60. [Crossref] [PubMed] [PMC]
- Marteau P. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease? Gut. 2006;55(12):1692-3. [Crossref] [PubMed] [PMC]
- Sanders ME. Probiotics: considerations for human health. Nutr Rev. 2003;61(3):91-9. [Crossref] [PubMed] [PMC]
- Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013;2:e01202. [Crossref] [PubMed] [PMC]
- Teng F, Klinger CN, Felix KM, Bradley CP, Wu E, Tran NL, et al. Gut microbiota drive autoimmune arthritis by promoting differentiation and migration of Peyer's patch T follicular helper cells. Immunity. 2016;44(4):875-88. [Crossref] [PubMed] [PMC]
- Yue M, Xia Y, Shi C, Guan C, Li Y, Liu R, et al. Berberine ameliorates collagen-induced arthritis in rats by suppressing Th17 cell responses via inducing cortistatin in the gut. FEBS J. 2017;284(17):2786-801. [Crossref] [PubMed]
- Yue M, Tao Y, Fang Y, Lian X, Zhang Q, Xia Y, et al. The gut microbiota modulator berberine ameliorates collagen-induced arthritis in rats by facilitating the generation of butyrate and adjusting the intestinal hypoxia and nitrate supply. FASEB J. 2019;33(11):12311-23. [Crossref] [PubMed] [PMC]
- Toden S, Bird AR, Topping DL, Conlon MA. Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol Ther. 2007;6(2):253-8. [Crossref] [PubMed]
- Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718-23. [Crossref] [PubMed] [PMC]
- McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-19. [Crossref] [PubMed]
- Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258-70. [Crossref] [PubMed] [PMC]
- Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895-905. [Crossref] [PubMed]
- Whitehouse MW. Rheumatoid arthritis and tuberculosis. Lancet. 1986;328(8508):688-9. [Crossref]
- Holoshitz J, Klajman A, Drucker I, Lapidot Z, Yaretzky A, Frenkel A, et al. T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet. 1986;2:305-09. [Crossref] [PubMed]
- Jethwa H, Abraham S. The evidence for microbiome manipulation in inflammatory arthritis. Rheumatology (Oxford). 2017;56(9): 1452-60. [PubMed]
- Kim MS, Hwang SS, Park EJ, Bae JW. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep. 2013;5(5):765-75. [Crossref] [PubMed]
- Alwarith J, Kahleova H, Rembert E, Yonas W, Dort S, Calcagno M, et al. Nutrition interventions in rheumatoid arthritis: the potential use of plant-based diets. A Review. Front Nutr. 2019;6:141. [Crossref] [PubMed] [PMC]
- Berthelot JM ,Sellam J, Maugars Y, Berenbaum F. Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis. RMD Open. 2019;5(2): e001037. [Crossref] [PubMed] [PMC]
- Woolf SH, Purnell JQ. The good life: working together to promote opportunity and improve population health and well-being. JAMA. 2016;315(16):1706-8. [Crossref] [PubMed]
- Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet. 2004;5:71-118. [Crossref] [PubMed]
- Ordovas JM, Ferguson LR, Tai ES, Mathers JC. Personalised nutrition and health. BMJ. 2018;361:bmj.k2173. [Crossref] [PubMed] [PMC]
- Nair N, Wilson AG. Can machine learning predict responses to TNF inhibitors? Nat Rev Rheumatol. 2019:702-4. [Crossref] [PubMed]
- DellaPenna D. Nutritional genomics: manipulating plant micronutrients to improve human health. Science. 1999;285(5426):375-9. [Crossref] [PubMed]
- Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902;2,1616-20. [Crossref]
- Leng G, Adan RAH, Belot M, Brunstrom JM, de Graaf K, Dickson SL, et al. The determinants of food choice. Proc Nutr Soc. 2017;76(3):316-27. [Crossref] [PubMed]
- Khanna S, Jaiswal KS, Gupta B. Managing rheumatoid arthritis with dietary interventions. Front Nutr. 2017;4:52. [Crossref] [PubMed] [PMC]
- Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376(9746):1094-108. [Crossref] [PubMed]
- El-Sohemy A. Nutrigenetics. Forum Nutr. 2007;60:25-30. [Crossref] [PubMed]
- Müller M, Kersten S. Nutrigenomics: goals and strategies. Nat Rev Genet. 2003;4(4):315-22. [Crossref] [PubMed]
- Willett WC. Balancing life-style and genomics research for disease prevention. Science. 2002;296(5568):695-8. [Crossref] [PubMed]
.: İşlem Listesi